Home » Topics » Musculoskeletal, BioWorld Science

Musculoskeletal, BioWorld Science
RSS

SuppreMol enters agreement to develop SM-401 for rheumatoid arthritis

July 27, 2012

Protalex reports on PRTX-100 trial in RA

July 27, 2012

Mesoblast product shuts down multiple cytokine pathways in arthritis model

July 26, 2012

First preclinical candidate drug selected in osteoarthritis alliance

July 25, 2012

PALACE-1 study of apremilast meets primary endpoint

July 13, 2012

Immune Response BioPharma plans phase III trial of rheumatoid arthritis vaccine

July 12, 2012

Japanese approval sought for subcutaneous arthritis drug

July 11, 2012

Xiaflex approved in Canada

July 10, 2012

FAS-specific antibody for arthritis shows promise in first clinical trial

July 2, 2012

Eisai and Toyama Chemical obtain approval in Japan for rheumatoid arthritis drug

June 29, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 10, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
FENS 2026: Shedding light on the sheddome
BioWorld
At the recently opened FENS Forum 2026 in Barcelona – the Federation of European Neuroscience Societies’ flagship congress and Europe’s largest neuroscience...
FENS 2026: Next-gen biologics take on brain disease
BioWorld
Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...